Dr. Wang and his team at CHOC are participating in a clinical trial of a drug intended to treat a rare pediatric disease called MPS IIIA.
CHOC receives $8 million to advance research for rare disorder
An $8 million gift from the Foundation of Caring will help CHOC advance research for a rare lysosomal storage disorder, Pompe Disease.
CHOC performs first in-human gene therapy dosing for MPS I
CHOC clinicians recently administered the first ever in-human dosing of gene therapy for Hurler Syndrome, a rare lysosomal storage disease.
From the Nursing Frontline of the Batten Disease Battle
CHOC recently hit its second anniversary of the first Brineura infusion, a novel treatment for CLN2 disease, or late infantile Batten disease.
CHOC at forefront of treating Batten disease
Bringing hope to patients and families, CHOC is among a few hospitals in the country to offer treatment for Late Infantile Batten disease.
CHOC Metabolic Specialist Profiled in Science Magazine
The work of a CHOC metabolic disorders specialist and is highlighted in a recent Science magazine article. The article hinges on Dr. Raymond Wang’s work to help a patient with a rare condition called Niemann-Pic Type C, a condition that causes cholesterol to accumulate in the brain, lungs, liver and spleen, leading to deterioration and […]